by healthadvances Posted on January 13, 2023 Reflections on BIOHK2022: Asia Biotech Market and the 2023 Outlook Read More
by healthadvances Posted on January 4, 2023 Maturation of Modalities and Targeting Strategies in Oncology: A Review of Recent and Upcoming Approvals Read More
by healthadvances Posted on July 6, 2022July 21, 2022 Xenotransplantation: Market Disrupter or Expander? Read More
by healthadvances Posted on May 2, 2022 Opportunities and Challenges for Drug Makers in MDD Read More
by healthadvances Posted on June 30, 2021 Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies? Read More
by healthadvances Posted on December 4, 2019April 13, 2020 Australian Biotechs and Medtechs: Look to the East Read More
by healthadvances Posted on February 27, 2019April 13, 2020 SHIFTING TIDES IN PHARMA DEALMAKING Read More
by healthadvances Posted on March 14, 2018April 15, 2020 Seattle’s Journey to the Summit of Cancer Commercialization Read More
